Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TAK-925, an orexin 2 receptor-selective agonist, shows robust wake-promoting effects in mice
Hiroshi Yukitake, Tatsuhiko Fujimoto, Takashi Ishikawa, et al.
Pharmacology Biochemistry and Behavior (2019) Vol. 187, pp. 172794-172794
Closed Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

European guideline and expert statements on the management of narcolepsy in adults and children
Claudio L. Bassetti, Ulf Kallweit, Luca Vignatelli, et al.
European Journal of Neurology (2021) Vol. 28, Iss. 9, pp. 2815-2830
Open Access | Times Cited: 115
Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation
Chuan Hong, Noel Byrne, Beata Zamlynny, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 104
Hypocretins (orexins): The ultimate translational neuropeptides
Laura H. Jacobson, Daniël Hoyer, Luı́s de Lecea
Journal of Internal Medicine (2022) Vol. 291, Iss. 5, pp. 533-556
Closed Access | Times Cited: 71
Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1
Yves Dauvilliers, Emmanuel Mignot, Rafael del Río Villegas, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 4, pp. 309-321
Closed Access | Times Cited: 40
The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress
Miklós Jászberényi, Balázs Thurzó, Zsolt Bagosi, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 448-448
Open Access | Times Cited: 22
Recent advances in treatment for narcolepsy
Lucie Barateau, Yves Dauvilliers
Therapeutic Advances in Neurological Disorders (2019) Vol. 12
Open Access | Times Cited: 84
European guideline and expert statements on the management of narcolepsy in adults and children
Claudio L. Bassetti, Ulf Kallweit, Luca Vignatelli, et al.
Journal of Sleep Research (2021) Vol. 30, Iss. 6
Open Access | Times Cited: 76
Orexin 2 receptor–selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients
Rebecca Evans, Haruhide Kimura, Robert Alexander, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 35
Open Access | Times Cited: 56
The orexin story, sleep and sleep disturbances
Fabio Pizza, Lucie Barateau, Yves Dauvilliers, et al.
Journal of Sleep Research (2022) Vol. 31, Iss. 4
Closed Access | Times Cited: 48
Effects of the orexin receptor 2 agonist danavorexton on emergence from general anaesthesia and opioid-induced sedation, respiratory depression, and analgesia in rats and monkeys
Motohisa Suzuki, Eri Shiraishi, James J. Cronican, et al.
British Journal of Anaesthesia (2024) Vol. 132, Iss. 3, pp. 541-552
Open Access | Times Cited: 8
Hypocretin/Orexin Receptor Pharmacology and Sleep Phases
Yu Sun, Ryan K. Tisdale, Thomas S. Kilduff
Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences (2021), pp. 22-37
Open Access | Times Cited: 42
Sleep-wake and arousal dysfunctions in post-traumatic stress disorder: Role of orexin systems
Gary B. Kaplan, Gabrielle A. Lakis, Hryhoriy Zhoba
Brain Research Bulletin (2022) Vol. 186, pp. 106-122
Closed Access | Times Cited: 32
Orexin 2 receptor‐selective agonist danavorexton ( TAK ‐925) promotes wakefulness in non‐human primates and healthy individuals
Rebecca Evans, Haruhide Kimura, Masato Nakashima, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 5
Open Access | Times Cited: 19
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19
Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor Agonist
Tatsuhiko Fujimoto, Kentaro Rikimaru, Koichiro Fukuda, et al.
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 3, pp. 457-462
Open Access | Times Cited: 26
Orexin Signaling: A Complex, Multifaceted Process
Natasha C. Dale, Daniël Hoyer, Laura H. Jacobson, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 26
Molecular mechanism of the wake-promoting agent TAK-925
Jie Yin, Yanyong Kang, Aaron P. McGrath, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24
TAK-994, a Novel Orally Available Brain-Penetrant Orexin 2 Receptor-Selective Agonist, Suppresses Fragmentation of Wakefulness and Cataplexy-Like Episodes in Mouse Models of Narcolepsy
Takashi Ishikawa, Hiroe Hara, Ayumi Kawano, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 385, Iss. 3, pp. 193-204
Open Access | Times Cited: 15
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13
Design and Synthesis of Orexin 1 Receptor-Selective Agonists
Keita Iio, Kao Hashimoto, Yasuyuki Nagumo, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 8, pp. 5453-5464
Open Access | Times Cited: 13
The present and future of synthetic orexin receptor agonists
Tsuyoshi Saitoh, Takeshi Sakurai
Peptides (2023) Vol. 167, pp. 171051-171051
Open Access | Times Cited: 13
Orexin receptor 2 agonist activates diaphragm and genioglossus muscle through stimulating inspiratory neurons in the pre-Bötzinger complex, and phrenic and hypoglossal motoneurons in rodents
Ryuji Yamada, Tatsuki Koike, Masanori Nakakariya, et al.
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0306099-e0306099
Open Access | Times Cited: 4
Narcolepsy and rapid eye movement sleep
Francesco Biscarini, Lucie Barateau, Fabio Pizza, et al.
Journal of Sleep Research (2024)
Open Access | Times Cited: 4
Expression and purification of an activated Orexin receptor 1- G-protein complex
Ioanna Ramou, Steven Janvier, Sarah Druwé, et al.
Protein Expression and Purification (2025) Vol. 228, pp. 106660-106660
Closed Access
Orexin/hypocretin receptor 2 signaling in MCH neurons regulates REM sleep and insulin sensitivity
Shuntaro Izawa, Debora Fuscà, Hong Jiang, et al.
Cell Reports (2025) Vol. 44, Iss. 2, pp. 115277-115277
Open Access
Page 1 - Next Page

Scroll to top